Literature DB >> 31337738

Alternative ZAP70-p38 signals prime a classical p38 pathway through LAT and SOS to support regulatory T cell differentiation.

Jesse E Jun1, Kayla R Kulhanek1, Hang Chen2, Arup Chakraborty2, Jeroen P Roose3.   

Abstract

T cell receptor (TCR) stimulation activates diverse kinase pathways, which include the mitogen-activated protein kinases (MAPKs) ERK and p38, the phosphoinositide 3-kinases (PI3Ks), and the kinase mTOR. Although TCR stimulation activates the p38 pathway through a "classical" MAPK cascade that is mediated by the adaptor protein LAT, it also stimulates an "alternative" pathway in which p38 is activated by the kinase ZAP70. Here, we used dual-parameter, phosphoflow cytometry and in silico computation to investigate how both classical and alternative p38 pathways contribute to T cell activation. We found that basal ZAP70 activation in resting T cell lines reduced the threshold ("primed") TCR-stimulated activation of the classical p38 pathway. Classical p38 signals were reduced after T cell-specific deletion of the guanine nucleotide exchange factors Sos1 and Sos2, which are essential LAT signalosome components. As a consequence of Sos1/2 deficiency, production of the cytokine IL-2 was impaired, differentiation into regulatory T cells was reduced, and the autoimmune disease EAE was exacerbated in mice. These data suggest that the classical and alternative p38 activation pathways exist to generate immune balance.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Year:  2019        PMID: 31337738      PMCID: PMC7340343          DOI: 10.1126/scisignal.aao0736

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  82 in total

1.  MAPK p38: alternative and nonstressful in T cells.

Authors:  Christopher E Rudd
Journal:  Nat Immunol       Date:  2005-04       Impact factor: 25.606

2.  The catalytic activity of the kinase ZAP-70 mediates basal signaling and negative feedback of the T cell receptor pathway.

Authors:  Hanna Sjölin Goodfellow; Maria P Frushicheva; Qinqin Ji; Arup K Chakraborty; Arthur Salomon; Arthur Weiss; Debra A Cheng; Theresa A Kadlecek; Aaron J Cantor; John Kuriyan
Journal:  Sci Signal       Date:  2015-05-19       Impact factor: 8.192

3.  Disruption of T cell signaling networks and development by Grb2 haploid insufficiency.

Authors:  Q Gong; A M Cheng; A M Akk; J Alberola-Ila; G Gong; T Pawson; A C Chan
Journal:  Nat Immunol       Date:  2001-01       Impact factor: 25.606

4.  Lack of the T cell-specific alternative p38 activation pathway reduces autoimmunity and inflammation.

Authors:  Ludmila Jirmanova; Maria Letizia Giardino Torchia; Nandakumara D Sarma; Paul R Mittelstadt; Jonathan D Ashwell
Journal:  Blood       Date:  2011-06-28       Impact factor: 22.113

Review 5.  Regulation and function of mTOR signalling in T cell fate decisions.

Authors:  Hongbo Chi
Journal:  Nat Rev Immunol       Date:  2012-04-20       Impact factor: 53.106

6.  Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site.

Authors:  P R Young; M M McLaughlin; S Kumar; S Kassis; M L Doyle; D McNulty; T F Gallagher; S Fisher; P C McDonnell; S A Carr; M J Huddleston; G Seibel; T G Porter; G P Livi; J L Adams; J C Lee
Journal:  J Biol Chem       Date:  1997-05-02       Impact factor: 5.157

7.  Targeting combinatorial transcriptional complex assembly at specific modules within the interleukin-2 promoter by the immunosuppressant SB203580.

Authors:  James L Smith; Irene Collins; G V R Chandramouli; Wayne G Butscher; Elena Zaitseva; Wendy J Freebern; Cynthia M Haggerty; Victoria Doseeva; Kevin Gardner
Journal:  J Biol Chem       Date:  2003-08-01       Impact factor: 5.157

8.  Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation.

Authors:  J H Hanke; J P Gardner; R L Dow; P S Changelian; W H Brissette; E J Weringer; B A Pollok; P A Connelly
Journal:  J Biol Chem       Date:  1996-01-12       Impact factor: 5.157

Review 9.  Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa.

Authors:  S A Khader; S L Gaffen; J K Kolls
Journal:  Mucosal Immunol       Date:  2009-07-08       Impact factor: 7.313

10.  Counter-regulation of T cell effector function by differentially activated p38.

Authors:  Muhammad S Alam; Matthias M Gaida; Youichi Ogawa; Antonios G A Kolios; Felix Lasitschka; Jonathan D Ashwell
Journal:  J Exp Med       Date:  2014-05-26       Impact factor: 14.307

View more
  3 in total

1.  Targeting the non-ATP-binding pocket of the MAP kinase p38γ mediates a novel mechanism of cytotoxicity in cutaneous T-cell lymphoma (CTCL).

Authors:  Xu Hannah Zhang; Chih-Hong Chen; Hongzhi Li; Jack Hsiang; Xiwei Wu; Weidong Hu; David Horne; Sangkil Nam; Jack Shively; Steven T Rosen
Journal:  FEBS Lett       Date:  2021-09-15       Impact factor: 3.864

Review 2.  Diversity and versatility of p38 kinase signalling in health and disease.

Authors:  Begoña Canovas; Angel R Nebreda
Journal:  Nat Rev Mol Cell Biol       Date:  2021-01-27       Impact factor: 113.915

3.  α1AMP-Activated Protein Kinase Protects against Lipopolysaccharide-Induced Endothelial Barrier Disruption via Junctional Reinforcement and Activation of the p38 MAPK/HSP27 Pathway.

Authors:  Marine Angé; Diego Castanares-Zapatero; Julien De Poortere; Cécile Dufeys; Guillaume E Courtoy; Caroline Bouzin; Rozenn Quarck; Luc Bertrand; Christophe Beauloye; Sandrine Horman
Journal:  Int J Mol Sci       Date:  2020-08-04       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.